S&P 500   3,012.97 (+0.21%)
DOW   26,840.93 (+0.05%)
QQQ   194.03 (+0.33%)
AAPL   240.96 (+0.19%)
FB   190.33 (+0.30%)
MSFT   139.48 (+0.76%)
GOOGL   1,245.26 (+0.08%)
AMZN   1,776.41 (-0.52%)
CGC   20.47 (+0.59%)
NVDA   198.19 (+1.11%)
BABA   173.79 (+0.16%)
GE   8.64 (-1.71%)
TSLA   253.79 (+0.11%)
AMD   31.88 (-0.47%)
T   37.95 (-0.73%)
F   8.99 (-0.44%)
ACB   3.63 (-1.63%)
PRI   124.94 (-0.60%)
NFLX   269.84 (-2.96%)
BAC   30.96 (-0.19%)
GILD   66.24 (+1.58%)
DIS   132.53 (+1.74%)
S&P 500   3,012.97 (+0.21%)
DOW   26,840.93 (+0.05%)
QQQ   194.03 (+0.33%)
AAPL   240.96 (+0.19%)
FB   190.33 (+0.30%)
MSFT   139.48 (+0.76%)
GOOGL   1,245.26 (+0.08%)
AMZN   1,776.41 (-0.52%)
CGC   20.47 (+0.59%)
NVDA   198.19 (+1.11%)
BABA   173.79 (+0.16%)
GE   8.64 (-1.71%)
TSLA   253.79 (+0.11%)
AMD   31.88 (-0.47%)
T   37.95 (-0.73%)
F   8.99 (-0.44%)
ACB   3.63 (-1.63%)
PRI   124.94 (-0.60%)
NFLX   269.84 (-2.96%)
BAC   30.96 (-0.19%)
GILD   66.24 (+1.58%)
DIS   132.53 (+1.74%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space
(ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Mersana TherapeuticsGlycoMimeticsBicycle TherapeuticsProMetic Life SciencesArdelyx
SymbolNASDAQ:MRSNNASDAQ:GLYCNASDAQ:BCYCOTCMKTS:PFSCFNASDAQ:ARDX
Price Information
Current Price$1.70$5.08$9.62$7.48$5.09
52 Week RangeBuyBuyBuyHoldBuy
Analyst Ratings
Consensus RecommendationBuyBuyBuyHoldBuy
Consensus Price Target$13.00$16.00$19.50N/A$11.00
% Upside from Price Target664.71% upside214.96% upside102.70% upsideN/A116.11% upside
Trade Information
Market Cap$78.89 million$221.13 million$170.27 million$174.46 million$308.35 million
Beta1.442.7N/A2.531.76
Average Volume408,525208,36218,157117529,904
Sales & Book Value
Annual Revenue$10.59 million$20,000.00$7.14 million$36.55 million$2.61 million
Price / Sales7.6710,970.2623.854.77122.47
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value$0.38 per share$4.76 per shareN/A($67.63) per share$1.86 per share
Price / Book4.471.07-0.112.74
Profitability
Net Income$-64,260,000.00$-48,270,000.00$-21,850,000.00$-150,730,000.00$-91,300,000.00
EPS($2.79)($1.18)N/AN/A($1.62)
Trailing P/E RatioN/AN/A0.000.00N/A
Forward P/E RatioN/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-77.78%N/AN/A-731.21%N/A
Return on Equity (ROE)-51.13%-27.88%N/A-3,350.55%-99.21%
Return on Assets (ROA)-30.04%-26.48%N/A-47.19%-59.70%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.06%0.02%N/AN/A0.77%
Current Ratio5.50%17.54%12.76%0.95%7.79%
Quick Ratio5.50%17.54%12.76%0.71%7.79%
Ownership Information
Institutional Ownership Percentage83.72%N/A37.23%0.10%72.82%
Insider Ownership Percentage29.20%26.80%N/AN/A15.31%
Miscellaneous
Employees86506148786
Shares Outstanding47.81 million43.19 million17.70 million23.31 million62.80 million
Next Earnings Date11/12/2019 (Estimated)11/1/2019 (Estimated)N/A11/13/2019 (Estimated)11/6/2019 (Estimated)
OptionableNot OptionableOptionableNot OptionableNot OptionableOptionable
 Mersana TherapeuticsGlycoMimeticsBicycle TherapeuticsProMetic Life SciencesArdelyx

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel